• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高分化3级胰腺神经内分泌肿瘤的基因组特征

Genomic characterization of a well-differentiated grade 3 pancreatic neuroendocrine tumor.

作者信息

Williamson Laura M, Steel Michael, Grewal Jasleen K, Thibodeau My Lihn, Zhao Eric Y, Loree Jonathan M, Yang Kevin C, Gorski Sharon M, Mungall Andrew J, Mungall Karen L, Moore Richard A, Marra Marco A, Laskin Janessa, Renouf Daniel J, Schaeffer David F, Jones Steven J M

机构信息

Canada's Michael Smith Genome Science Centre, BC Cancer, Vancouver, British Columbia V5Z 4S6, Canada.

Department of Pathology & Laboratory Medicine, Vancouver General Hospital, Vancouver, British Columbia V6T 2B5, Canada.

出版信息

Cold Spring Harb Mol Case Stud. 2019 Jun 3;5(3). doi: 10.1101/mcs.a003814. Print 2019 Jun.

DOI:10.1101/mcs.a003814
PMID:31160355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6549554/
Abstract

Pancreatic neuroendocrine neoplasms (PanNENs) represent a minority of pancreatic neoplasms that exhibit variability in prognosis. Ongoing mutational analyses of PanNENs have found recurrent abnormalities in chromatin remodeling genes (e.g., and ), and mTOR pathway genes (e.g., , , and ), some of which have relevance to patients with related familial syndromes. Most recently, grade 3 PanNENs have been divided into two groups based on differentiation, creating a new group of well-differentiated grade 3 neuroendocrine tumors (PanNETs) that have had a limited whole-genome level characterization to date. In a patient with a metastatic well-differentiated grade 3 PanNET, our study utilized whole-genome sequencing of liver metastases for the comparative analysis and detection of single-nucleotide variants, insertions and deletions, structural variants, and copy-number variants, with their biologic relevance confirmed by RNA sequencing. We found that this tumor most notably exhibited a -disrupting fusion, showed a novel fusion, and lacked any somatic variants in , , and .

摘要

胰腺神经内分泌肿瘤(PanNENs)占胰腺肿瘤的少数,其预后存在差异。对PanNENs进行的持续突变分析发现,染色质重塑基因(如……和……)以及mTOR通路基因(如……、……和……)存在反复出现的异常,其中一些与相关家族综合征患者有关。最近,3级PanNENs根据分化情况被分为两组,形成了一组新的高分化3级神经内分泌肿瘤(PanNETs),迄今为止,这组肿瘤在全基因组水平上的特征有限。在一名转移性高分化3级PanNET患者中,我们的研究利用肝转移灶的全基因组测序进行比较分析,并检测单核苷酸变异、插入和缺失、结构变异以及拷贝数变异,通过RNA测序证实了它们的生物学相关性。我们发现,该肿瘤最显著的表现是一个……破坏融合,显示出一种新的……融合,并且在……、……和……中没有任何体细胞变异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/915c/6549554/4a687ddcb1da/MCS003814Wil_F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/915c/6549554/34f0228f4ee9/MCS003814Wil_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/915c/6549554/e00d250eb219/MCS003814Wil_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/915c/6549554/10ea8196ab8f/MCS003814Wil_F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/915c/6549554/4a687ddcb1da/MCS003814Wil_F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/915c/6549554/34f0228f4ee9/MCS003814Wil_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/915c/6549554/e00d250eb219/MCS003814Wil_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/915c/6549554/10ea8196ab8f/MCS003814Wil_F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/915c/6549554/4a687ddcb1da/MCS003814Wil_F4.jpg

相似文献

1
Genomic characterization of a well-differentiated grade 3 pancreatic neuroendocrine tumor.高分化3级胰腺神经内分泌肿瘤的基因组特征
Cold Spring Harb Mol Case Stud. 2019 Jun 3;5(3). doi: 10.1101/mcs.a003814. Print 2019 Jun.
2
Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times.染色质重塑蛋白和/或 CDKN2A 的缺失与胰腺神经内分泌肿瘤的转移和患者生存时间的减少有关。
Gastroenterology. 2018 Jun;154(8):2060-2063.e8. doi: 10.1053/j.gastro.2018.02.026. Epub 2018 Mar 2.
3
Site-Specific Genomic Alterations in a Well-Differentiated Pancreatic Neuroendocrine Tumor With High-Grade Progression.伴有高级别进展的高分化胰腺神经内分泌肿瘤中的位点特异性基因组改变
Pancreas. 2018 Apr;47(4):502-510. doi: 10.1097/MPA.0000000000001030.
4
Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors.DAXX 和 ATRX 的缺失与染色体不稳定性和胰腺神经内分泌肿瘤患者的生存降低有关。
Gastroenterology. 2014 Feb;146(2):453-60.e5. doi: 10.1053/j.gastro.2013.10.020. Epub 2013 Oct 19.
5
DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors.DAXX/ATRX、MEN1 和 mTOR 通路基因在胰腺神经内分泌肿瘤中经常发生改变。
Science. 2011 Mar 4;331(6021):1199-203. doi: 10.1126/science.1200609. Epub 2011 Jan 20.
6
Multiregion WES of metastatic pancreatic neuroendocrine tumors revealed heterogeneity in genomic alterations, immune microenvironment and evolutionary patterns.多区域 WES 分析转移性胰腺神经内分泌肿瘤揭示了基因组改变、免疫微环境和进化模式的异质性。
Cell Commun Signal. 2024 Mar 6;22(1):164. doi: 10.1186/s12964-024-01545-6.
7
Exome-level comparison of primary well-differentiated neuroendocrine tumors and their cell lines.原发性高分化神经内分泌肿瘤及其细胞系的外显子水平比较。
Cancer Genet. 2015 Jul-Aug;208(7-8):374-81. doi: 10.1016/j.cancergen.2015.04.002. Epub 2015 Apr 14.
8
Well-differentiated G1 and G2 pancreatic neuroendocrine tumors: a meta-analysis of published expanded DNA sequencing data.高分化G1和G2胰腺神经内分泌肿瘤:已发表的扩展DNA测序数据的荟萃分析
Front Endocrinol (Lausanne). 2024 May 29;15:1351624. doi: 10.3389/fendo.2024.1351624. eCollection 2024.
9
Immunohistochemically Detected Expression of ATRX, TSC2, and PTEN Predicts Clinical Outcomes in Patients With Grade 1 and 2 Pancreatic Neuroendocrine Tumors.免疫组织化学检测 ATRX、TSC2 和 PTEN 的表达可预测 1 级和 2 级胰腺神经内分泌肿瘤患者的临床结局。
Ann Surg. 2021 Dec 1;274(6):e949-e956. doi: 10.1097/SLA.0000000000003624.
10
Pancreatic neuroendocrine neoplasms: Updates on genomic changes in inherited tumour syndromes and sporadic tumours based on WHO classification.胰腺神经内分泌肿瘤:基于世卫组织分类的遗传性肿瘤综合征和散发性肿瘤中基因组改变的最新信息。
Crit Rev Oncol Hematol. 2022 Apr;172:103648. doi: 10.1016/j.critrevonc.2022.103648. Epub 2022 Mar 4.

引用本文的文献

1
The full-length BEND2 protein is dispensable for spermatogenesis but required for setting the ovarian reserve in mice.全长BEND2蛋白对小鼠精子发生并非必需,但对建立卵巢储备是必需的。
Elife. 2025 Aug 20;13:RP96052. doi: 10.7554/eLife.96052.
2
Genomic and transcriptomic landscapes of metastatic neuroendocrine neoplasms from distinct primary sites and their clinical implications.不同原发部位转移性神经内分泌肿瘤的基因组和转录组图谱及其临床意义。
Sci Rep. 2025 May 6;15(1):15770. doi: 10.1038/s41598-025-00549-7.
3
EWSR1::BEND2 fusion sarcoma in bone: a report of two rare cases.

本文引用的文献

1
MAVIS: merging, annotation, validation, and illustration of structural variants.MAVIS:结构变异的合并、注释、验证和说明。
Bioinformatics. 2019 Feb 1;35(3):515-517. doi: 10.1093/bioinformatics/bty621.
2
Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer.同源重组缺陷与晚期乳腺癌的铂类药物治疗结局。
Clin Cancer Res. 2017 Dec 15;23(24):7521-7530. doi: 10.1158/1078-0432.CCR-17-1941.
3
Molecular characterization of metastatic pancreatic neuroendocrine tumors (PNETs) using whole-genome and transcriptome sequencing.
骨内EWSR1::BEND2融合肉瘤:两例罕见病例报告
Virchows Arch. 2025 Apr;486(4):877-885. doi: 10.1007/s00428-025-04063-z. Epub 2025 Mar 5.
4
Malignant Bone-Forming Neoplasm With NIPBL::BEND2 Fusion.伴 NIPBL::BEND2 融合的恶性成骨新生物。
Genes Chromosomes Cancer. 2024 Nov;63(11):e70015. doi: 10.1002/gcc.70015.
5
Radiopharmaceuticals for Pancreatic Cancer: A Review of Current Approaches and Future Directions.用于胰腺癌的放射性药物:当前方法与未来方向综述
Pharmaceuticals (Basel). 2024 Oct 1;17(10):1314. doi: 10.3390/ph17101314.
6
An Insight on Functioning Pancreatic Neuroendocrine Neoplasms.关于功能性胰腺神经内分泌肿瘤的见解
Biomedicines. 2023 Jan 21;11(2):303. doi: 10.3390/biomedicines11020303.
7
Gene fusions are frequent in ACTH-secreting neuroendocrine neoplasms of the pancreas, but not in their non-pancreatic counterparts.胰腺促肾上腺皮质激素(ACTH)分泌性神经内分泌肿瘤中经常发生基因融合,但在非胰腺神经内分泌肿瘤中则不然。
Virchows Arch. 2023 Mar;482(3):507-516. doi: 10.1007/s00428-022-03484-4. Epub 2023 Jan 24.
8
The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different Prognoses.利用PDX1 DNA甲基化区分两种预后不同的胰腺神经内分泌肿瘤亚型。
Cancers (Basel). 2022 Dec 27;15(1):160. doi: 10.3390/cancers15010160.
9
Risk Stratification of Pancreatic Neuroendocrine Neoplasms Based on Clinical, Pathological, and Molecular Characteristics.基于临床、病理和分子特征的胰腺神经内分泌肿瘤风险分层
J Clin Med. 2022 Dec 15;11(24):7456. doi: 10.3390/jcm11247456.
10
Thymidylate synthase accelerates Men1-mediated pancreatic tumor progression and reduces survival.胸苷酸合成酶加速 Men1 介导的胰腺肿瘤进展并降低存活率。
JCI Insight. 2022 Oct 10;7(19):e147417. doi: 10.1172/jci.insight.147417.
使用全基因组和转录组测序对转移性胰腺神经内分泌肿瘤(PNETs)进行分子特征分析。
Cold Spring Harb Mol Case Stud. 2018 Feb 1;4(1). doi: 10.1101/mcs.a002329. Print 2018 Feb.
4
Successful targeting of the NRG1 pathway indicates novel treatment strategy for metastatic cancer.成功靶向 NRG1 通路为转移性癌症提供了新的治疗策略。
Ann Oncol. 2017 Dec 1;28(12):3092-3097. doi: 10.1093/annonc/mdx523.
5
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.美国神经内分泌肿瘤患者的发病率、患病率和生存结局趋势。
JAMA Oncol. 2017 Oct 1;3(10):1335-1342. doi: 10.1001/jamaoncol.2017.0589.
6
Whole-genome landscape of pancreatic neuroendocrine tumours.胰腺神经内分泌肿瘤的全基因组图谱。
Nature. 2017 Mar 2;543(7643):65-71. doi: 10.1038/nature21063. Epub 2017 Feb 15.
7
Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study.依维莫司治疗晚期胰腺神经内分泌肿瘤:来自随机III期RADIANT-3研究的总生存期及循环生物标志物
J Clin Oncol. 2016 Nov 10;34(32):3906-3913. doi: 10.1200/JCO.2016.68.0702. Epub 2016 Sep 30.
8
Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement.胃肠胰高分化3级神经内分泌肿瘤:综述与立场声明
Oncologist. 2016 Oct;21(10):1191-1199. doi: 10.1634/theoncologist.2015-0476. Epub 2016 Jul 8.
9
A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.胰腺WHO 3级(G3)高分化神经内分泌肿瘤(WD-NET)和低分化神经内分泌癌(PD-NEC)分类的实用方法
Am J Surg Pathol. 2016 Sep;40(9):1192-202. doi: 10.1097/PAS.0000000000000662.
10
Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers.从全基因组分析在晚期癌症患者治疗中的应用中吸取的经验教训。
Cold Spring Harb Mol Case Stud. 2015 Oct;1(1):a000570. doi: 10.1101/mcs.a000570.